XORTX Therapeutics XRTX
NASDAQ XRTX
$1.73 +0.04 (+2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Accumulated Expenses (2020 - 2021)

Updated

XORTX Therapeutics' Accumulated Expenses came in at $230,304 for the quarter ended Dec 31, 2021, down 53.4% from $494,160 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Accumulated Expenses (2020 - 2021) Analysis & Trends

As of Dec 31, 2021, XORTX Therapeutics' Accumulated Expenses was $231,645, down 51.8% from the prior year.

  • Going back by year, Accumulated Expenses was $480,905 in the year ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 230,303.88
Dec 31, 2020 494,160.39
API Access

XORTX Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY